VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,174 | -3.6% | 10,228 | +47.0% | 0.00% | – |
| Q2 2023 | $45,833 | +6.0% | 6,957 | +9.3% | 0.00% | – |
| Q1 2023 | $43,221 | +35.1% | 6,367 | +43.6% | 0.00% | – |
| Q4 2022 | $32,000 | -31.9% | 4,435 | -7.7% | 0.00% | – |
| Q3 2022 | $47,000 | -21.7% | 4,805 | -13.2% | 0.00% | – |
| Q2 2022 | $60,000 | -3.2% | 5,535 | +3.0% | 0.00% | – |
| Q1 2022 | $62,000 | -20.5% | 5,373 | +8.7% | 0.00% | – |
| Q4 2021 | $78,000 | +5.4% | 4,944 | +13.1% | 0.00% | – |
| Q3 2021 | $74,000 | -20.4% | 4,372 | +0.7% | 0.00% | – |
| Q2 2021 | $93,000 | +60.3% | 4,342 | +13.7% | 0.00% | – |
| Q1 2021 | $58,000 | +31.8% | 3,819 | +13.9% | 0.00% | – |
| Q4 2020 | $44,000 | +51.7% | 3,352 | +23.0% | 0.00% | – |
| Q3 2020 | $29,000 | -32.6% | 2,726 | -27.0% | 0.00% | – |
| Q2 2020 | $43,000 | +53.6% | 3,732 | +43.0% | 0.00% | – |
| Q1 2020 | $28,000 | – | 2,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |